Drug Type Contrast agent |
Synonyms 99mTc-1-TG |
Target- |
Action enhancers |
Mechanism PET imaging(Positron-emission tomography enhancers) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseClinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Glioma | Clinical | Russia | 15 Feb 2026 | |
| Malignant glioma of brain | Clinical | Russia | 15 Feb 2026 | |
| Neoplasms | Preclinical | South Korea | 01 Feb 2006 |





